Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Lymphatic Metastasis 2Colonic Neoplasms 2Thyroid Cancer, Papillary 1Stomach Neoplasms 1Neoplastic Cells, Circulating 1Kidney Neoplasms 1

Interventions

Oxaliplatin 27Fluorouracil 23Leucovorin 22Cetuximab 22Bevacizumab 21Nivolumab 16Capecitabine 16Irinotecan 15pembrolizumab 11Magnetic Resonance Spectroscopy 11Specimen Handling 10encorafenib 8Folfox protocol 7trifluridine tipiracil drug combination 6Ipilimumab 6Exercise 6fludarabine 5cemiplimab 5Trastuzumab 5Gemcitabine 5Cyclophosphamide 5Cisplatin 5Blood Specimen Collection 5Biopsy 5regorafenib 4pertuzumab 4adagrasib 4Trifluridine 4Pemetrexed 4Immune Checkpoint Inhibitors 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Colonic Neoplasms × Conversion to Open Surgery × 1 year × Clear all
NCT07314996 2026-06-03

LOVO

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase NA Recruiting
664 enrolled
Gastrointestinal

Colonic Neoplasms

NCT03776591 2026-05-14

D3/CME

Haraldsplass Deaconess Hospital

Phase NA Active not recruiting
128 enrolled
Gastrointestinal

Colonic Neoplasms, Lymphatic Metastasis, Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡